Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$237.03
5.372.32%
al cierre: -
$237.00
-0.03-0.01%
After hour: 6:15 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Salesforce Inc ha un obiettivo di prezzo di consenso pari a $352.24, stabilito in base alle ultime valutazioni degli analisti di 34. Le ultime 3 valutazioni degli analisti sono state rilasciate da Stifel, JMP Securities y RBC Capital il agosto 13, 2025, julio 16, 2025 y julio 14, 2025. Con un obiettivo di prezzo medio di $343.33 tra le Stifel, JMP Securities y RBC Capital, c'è un implicito 44.87% upside per Salesforce Inc da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
Stifel
JMP Securities
RBC Capital
BMO Capital
Cantor Fitzgerald
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Salesforce
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
08/13/2025 | 37.13% | Stifel | $375 → $325 | Maintains | Buy | |||
07/16/2025 | 81.43% | JMP Securities | $430 → $430 | Reiterates | Market Outperform → Market Outperform | |||
07/14/2025 | 16.03% | RBC Capital | $275 → $275 | Maintains | Sector Perform | |||
07/11/2025 | 81.43% | JMP Securities | $430 → $430 | Reiterates | Market Outperform → Market Outperform | |||
07/10/2025 | 41.35% | BMO Capital | $350 → $335 | Maintains | Outperform | |||
06/26/2025 | 37.13% | Cantor Fitzgerald | $325 → $325 | Reiterates | Overweight → Overweight | |||
06/20/2025 | 37.13% | Cantor Fitzgerald | $325 → $325 | Reiterates | Overweight → Overweight | |||
06/10/2025 | 56.12% | Oppenheimer | $370 → $370 | Reiterates | Outperform → Outperform | |||
06/03/2025 | 37.13% | Cantor Fitzgerald | → $325 | Initiates | → Overweight | |||
05/30/2025 | 24.47% | Citigroup | $320 → $295 | Maintains | Neutral | |||
05/30/2025 | 30.38% | Stephens & Co. | $311 → $309 | Maintains | Equal-Weight | |||
05/29/2025 | 16.03% | Wells Fargo | $255 → $275 | Maintains | Equal-Weight | |||
05/29/2025 | 41.35% | Piper Sandler | $315 → $335 | Maintains | Overweight | |||
05/29/2025 | 56.12% | Oppenheimer | $380 → $370 | Maintains | Outperform | |||
05/29/2025 | 67.09% | Northland Capital Markets | $423 → $396 | Maintains | Outperform | |||
05/29/2025 | 70.46% | Morgan Stanley | $393 → $404 | Maintains | Overweight | |||
05/29/2025 | 46.41% | Barclays | $425 → $347 | Maintains | Overweight | |||
05/29/2025 | -5.06% | DA Davidson | $200 → $225 | Maintains | Underperform | |||
05/29/2025 | 62.45% | Goldman Sachs | $340 → $385 | Maintains | Buy | |||
05/29/2025 | 7.59% | Bernstein | $243 → $255 | Maintains | Underperform | |||
05/29/2025 | 16.03% | RBC Capital | $420 → $275 | Downgrade | Outperform → Sector Perform | |||
05/29/2025 | 35.02% | WestPark Capital | $320 → $320 | Reiterates | Buy → Buy | |||
05/29/2025 | 68.78% | Needham | $400 → $400 | Reiterates | Buy → Buy | |||
05/28/2025 | -15.61% | DA Davidson | $200 → $200 | Maintains | Underperform | |||
05/28/2025 | 47.68% | Canaccord Genuity | $400 → $350 | Maintains | Buy | |||
05/28/2025 | 35.02% | WestPark Capital | $320 → $320 | Reiterates | Buy → Buy | |||
05/28/2025 | 68.78% | Needham | $400 → $400 | Reiterates | Buy → Buy | |||
05/27/2025 | 43.46% | Goldman Sachs | $340 → $340 | Reiterates | Buy → Buy | |||
05/27/2025 | 26.58% | UBS | $320 → $300 | Maintains | Neutral | |||
05/27/2025 | 47.68% | BMO Capital | $367 → $350 | Maintains | Outperform | |||
05/23/2025 | 35.02% | Citigroup | $335 → $320 | Maintains | Neutral | |||
05/21/2025 | 35.02% | UBS | $340 → $320 | Maintains | Neutral | |||
05/15/2025 | 60.34% | Mizuho | $425 → $380 | Maintains | Outperform | |||
04/30/2025 | 35.02% | WestPark Capital | $320 → $320 | Reiterates | Buy → Buy | |||
04/25/2025 | 68.78% | Needham | $400 → $400 | Reiterates | Buy → Buy | |||
04/24/2025 | 43.46% | Goldman Sachs | $400 → $340 | Maintains | Buy | |||
04/23/2025 | 32.91% | Piper Sandler | $400 → $315 | Maintains | Overweight | |||
04/22/2025 | 7.59% | Wells Fargo | $310 → $255 | Maintains | Equal-Weight | |||
04/21/2025 | — | Guggenheim | — | Upgrade | Sell → Neutral | |||
04/21/2025 | -15.61% | DA Davidson | → $200 | Downgrade | Neutral → Underperform | |||
04/16/2025 | 65.82% | Morgan Stanley | — | $405 → $393 | Maintains | Overweight | ||
04/14/2025 | 5.49% | DA Davidson | $275 → $250 | Maintains | Neutral | |||
03/31/2025 | 58.23% | Jefferies | $425 → $375 | Maintains | Buy | |||
03/20/2025 | 35.02% | Macquarie | $320 → $320 | Maintains | Neutral | |||
03/19/2025 | — | Stephens & Co. | — | Initiates | → Equal-Weight | |||
03/17/2025 | 45.57% | Scotiabank | $400 → $345 | Maintains | Sector Outperform | |||
03/08/2025 | 68.78% | Goldman Sachs | $400 → $400 | Maintains | Buy | |||
02/28/2025 | 41.35% | Citigroup | $350 → $335 | Maintains | Neutral | |||
02/27/2025 | 43.46% | UBS | $360 → $340 | Maintains | Neutral | |||
02/27/2025 | 68.78% | Goldman Sachs | $400 → $400 | Maintains | Buy | |||
02/27/2025 | 68.78% | Canaccord Genuity | $415 → $400 | Maintains | Buy | |||
02/27/2025 | 26.58% | Loop Capital | $330 → $300 | Maintains | Hold | |||
02/27/2025 | 16.03% | DA Davidson | $300 → $275 | Maintains | Neutral | |||
02/27/2025 | 68.78% | Scotiabank | $440 → $400 | Maintains | Sector Outperform | |||
02/27/2025 | 35.02% | Macquarie | $370 → $320 | Maintains | Neutral | |||
02/27/2025 | 54.85% | BMO Capital | $375 → $367 | Maintains | Outperform | |||
02/27/2025 | 4.22% | Guggenheim | $247 → $247 | Reiterates | Sell → Sell | |||
02/27/2025 | 58.23% | Stifel | $425 → $375 | Maintains | Buy | |||
02/27/2025 | 68.78% | Baird | $430 → $400 | Maintains | Outperform | |||
02/27/2025 | 60.34% | Oppenheimer | $415 → $380 | Maintains | Outperform | |||
02/27/2025 | 68.78% | Needham | $400 → $400 | Reiterates | Buy → Buy | |||
02/27/2025 | 68.78% | B of A Securities | $440 → $400 | Maintains | Buy | |||
02/27/2025 | 68.78% | Piper Sandler | $405 → $400 | Maintains | Overweight | |||
02/27/2025 | 30.8% | Wells Fargo | $345 → $310 | Maintains | Equal-Weight | |||
02/25/2025 | 47.68% | Citigroup | $390 → $350 | Maintains | Neutral | |||
02/24/2025 | 89.87% | Citizens Capital Markets | $450 → $450 | Reiterates | Market Outperform → Market Outperform | |||
02/21/2025 | 58.23% | BMO Capital | $425 → $375 | Maintains | Outperform | |||
02/19/2025 | 39.24% | Loop Capital | $360 → $330 | Maintains | Hold | |||
02/10/2025 | 68.78% | Needham | $400 → $400 | Reiterates | Buy → Buy | |||
02/06/2025 | 68.78% | Needham | $400 → $400 | Reiterates | Buy → Buy | |||
01/17/2025 | 68.78% | TD Cowen | $380 → $400 | Upgrade | Hold → Buy | |||
01/08/2025 | 68.78% | Needham | $375 → $400 | Maintains | Buy | |||
01/06/2025 | 4.22% | Guggenheim | $247 → $247 | Downgrade | Neutral → Sell | |||
12/18/2024 | 56.12% | Macquarie | $370 → $370 | Maintains | Neutral | |||
12/18/2024 | 89.87% | JMP Securities | $450 → $450 | Reiterates | Market Outperform → Market Outperform | |||
12/18/2024 | 79.32% | Wedbush | $425 → $425 | Reiterates | Outperform → Outperform | |||
12/18/2024 | 58.23% | Needham | $375 → $375 | Reiterates | Buy → Buy | |||
12/18/2024 | 70.89% | Piper Sandler | $405 → $405 | Maintains | Overweight | |||
12/12/2024 | 56.12% | Macquarie | → $370 | Initiates | → Neutral | |||
12/04/2024 | 79.32% | Jefferies | $400 → $425 | Maintains | Buy | |||
12/04/2024 | 60.34% | JP Morgan | $340 → $380 | Maintains | Overweight | |||
12/04/2024 | 51.9% | Loop Capital | $340 → $360 | Maintains | Hold | |||
12/04/2024 | 77.22% | RBC Capital | $300 → $420 | Maintains | Outperform | |||
12/04/2024 | 64.56% | Citigroup | $368 → $390 | Maintains | Neutral | |||
12/04/2024 | 26.58% | DA Davidson | $300 → $300 | Maintains | Neutral | |||
12/04/2024 | 89.87% | JMP Securities | $450 → $450 | Reiterates | Market Outperform → Market Outperform | |||
12/04/2024 | 85.65% | Scotiabank | $425 → $440 | Maintains | Sector Outperform | |||
12/04/2024 | 75.11% | Canaccord Genuity | $315 → $415 | Maintains | Buy | |||
12/04/2024 | 68.78% | Goldman Sachs | $360 → $400 | Maintains | Buy | |||
12/04/2024 | 75.11% | Oppenheimer | $385 → $415 | Reiterates | Outperform → Outperform | |||
12/04/2024 | 79.32% | BMO Capital | $385 → $425 | Maintains | Outperform | |||
12/04/2024 | — | Guggenheim | — | Reiterates | Neutral → Neutral | |||
12/04/2024 | 68.78% | Truist Securities | $380 → $400 | Reiterates | Buy → Buy | |||
12/04/2024 | 79.32% | Stifel | $390 → $425 | Maintains | Buy | |||
12/04/2024 | 70.89% | Morgan Stanley | $330 → $405 | Maintains | Overweight | |||
12/04/2024 | 85.65% | B of A Securities | $390 → $440 | Maintains | Buy | |||
12/04/2024 | 85.65% | Northland Capital Markets | $400 → $440 | Reiterates | Outperform → Outperform | |||
12/04/2024 | 81.43% | Baird | $340 → $430 | Maintains | Outperform | |||
12/04/2024 | 58.23% | Needham | $345 → $375 | Maintains | Buy | |||
12/04/2024 | 79.32% | Barclays | $415 → $425 | Maintains | Overweight |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Salesforce (CRM)?
El último precio objetivo de Salesforce (NYSE:CRM) fue comunicado por Stifel el agosto 13, 2025. La firma de analistas fijó un precio objetivo para $325.00 que espera CRM a rise dentro de 12 meses (un posible 37.13% upside). 100 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Salesforce (CRM)?
La última calificación de analistas para Salesforce (NYSE:CRM) fue proporcionada por Stifel, y Salesforce mantuvo su buy calificación.
¿Cuándo se produjo la última revisión al alza de Salesforce (CRM)?
La última revisión al alza de Salesforce Inc se produjo en abril 21, 2025, cuando Guggenheim elevó su precio objetivo a N/A. Guggenheim anteriormente tenía a sell para Salesforce Inc.
¿Cuándo fue la última revisión a la baja de Salesforce (CRM)?
La última revisión a la baja de Salesforce Inc se produjo en mayo 29, 2025, cuando RBC Capital cambió su precio objetivo de $420 a $275 para Salesforce Inc.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Salesforce (CRM)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Salesforce, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Salesforce se registró el agosto 13, 2025, por lo que la próxima calificación estará disponible en torno al agosto 13, 2026.
¿Es correcta la calificación de los analistas sobre Salesforce (CRM)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Salesforce (CRM) fue un mantuvo con un precio objetivo de $375.00 a $325.00. El precio actual al que cotiza Salesforce (CRM) es de $237.00, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.